Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence"

被引：0

作者：

Yang, Ju Dong ^{[1
]}

Leise, Michael D. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 06期

关键词：

SOFOSBUVIR PLUS RIBAVIRIN; ADVANCED LIVER-DISEASE; LEDIPASVIR; INFECTION;

D O I：

10.1016/j.jhep.2017.08.001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1357 / 1357

页数：1

共 6 条

[1] Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma [J].

Beste, Lauren A. ;

Green, Pamela K. ;

Berry, Kristin ;

Kogut, Matthew J. ;

Allison, Stephen K. ;

Ioannou, George N. .

JOURNAL OF HEPATOLOGY, 2017, 67 (01) :32-39

[2] Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease [J].

Charlton, Michael ;

Everson, Gregory T. ;

Flamm, Steven L. ;

Kumar, Princy ;

Landis, Charles ;

Brown, Robert S., Jr. ;

Fried, Michael W. ;

Terrault, Norah A. ;

O'Leary, Jacqueline G. ;

Vargas, Hugo E. ;

Kuo, Alexander ;

Schiff, Eugene ;

Sulkowski, Mark S. ;

Gilroy, Richard ;

Watt, Kymberly D. ;

Brown, Kimberly ;

Kwo, Paul ;

Pungpapong, Surakit ;

Korenblat, Kevin M. ;

Muir, Andrew J. ;

Teperman, Lewis ;

Fontana, Robert J. ;

Denning, Jill ;

Arterburn, Sarah ;

Dvory-Sobol, Hadas ;

Brandt-Sarif, Theo ;

Pang, Phillip S. ;

McHutchison, John G. ;

Reddy, K. Rajender ;

Afdhal, Nezam .

GASTROENTEROLOGY, 2015, 149 (03) :649-659

[3] Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial [J].

Manns, Michael ;

Samuel, Didier ;

Gane, Edward J. ;

Mutimer, David ;

McCaughan, Geoff ;

Buti, Maria ;

Prieto, Martin ;

Luis Calleja, Jose ;

Peck-Radosavljevic, Markus ;

Mullhaupt, Beat ;

Agarwal, Kosh ;

Angus, Peter ;

Yoshida, Eric M. ;

Colombo, Massimo ;

Rizzetto, Mario ;

Dvory-Sobol, Hadas ;

Denning, Jill ;

Arterburn, Sarah ;

Pang, Phillip S. ;

Brainard, Diana ;

McHutchison, John G. ;

Dufour, Jean-Francois ;

Van Vlierberghe, Hans ;

van Hoek, Bart ;

Forns, Xavier .

LANCET INFECTIOUS DISEASES, 2016, 16 (06) :685-697

[4] Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals [J].

Prenner, Stacey B. ;

VanWagner, Lisa B. ;

Flamm, Steven L. ;

Salem, Riad ;

Lewandowski, Robert J. ;

Kulik, Laura .

JOURNAL OF HEPATOLOGY, 2017, 66 (06) :1173-1181

[5] Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma [J].

Yang, Ju Dong ;

Aqel, Bashar A. ;

Pungpapong, Surakit ;

Gores, Gregory J. ;

Roberts, Lewis R. ;

Leise, Michael D. .

JOURNAL OF HEPATOLOGY, 2016, 65 (04) :859-860

[6] Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial [J].

Younossi, Zobair M. ;

Stepanova, Maria ;

Charlton, Michael ;

Curry, Michael P. ;

O'Leary, Jacqueline G. ;

Brown, Robert S. ;

Hunt, Sharon .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (02) :122-132

← 1 →